Schonfeld Strategic Advisors LLC Allakos Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Allakos Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 32,800 shares of ALLK stock, worth $43,952. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,800Holding current value
$43,952% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding ALLK
# of Institutions
101Shares Held
70.7MCall Options Held
43.8KPut Options Held
1.4K-
Bvf Inc San Francisco, CA16.6MShares$22.2 Million0.51% of portfolio
-
Nea Management Company, LLC Timonium, MD6.15MShares$8.24 Million0.58% of portfolio
-
Deep Track Capital, LP Greenwich, CT5MShares$6.7 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$4.71 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.42MShares$4.59 Million0.0% of portfolio
About Allakos Inc.
- Ticker ALLK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,726,096
- Market Cap $114M
- Description
- Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...